The Centre for Drug Research and Development:企業のM&A・提携動向(医療分野)

【英語タイトル】The Centre for Drug Research and Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(GDPH250701D)・商品コード:GDPH250701D
・発行会社(調査会社):GlobalData
・発行日:2016年12月13日
・ページ数:26
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥55,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥83,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
The Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides infrastructure to transform basic health research in academic institutions and early-stage therapeutic technologies. The center provides research services in the therapeutic areas of infectious disease, metabolic, oncology, neuroscience, and others. It partners with QLT Inc., Johnson & Johnson, Genome BC, Pfizer, Roche, Angiotech, and others. CDRD sources, evaluates, develops and commercializes small molecule and biologic innovative technologies. The center’s institutions include BC Cancer Agency, TEC Edmonton, MaRS Innovation, McGill, Providence health care, and others. CDRD is headquartered in Vancouver, British Columbia, Canada.

The Centre for Drug Research and Development – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The Centre for Drug Research and Development, Medical Devices Deals, 2010 to YTD 2016 9
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Centre for Drug Research and Development Partners with AstraZeneca 12
Centre for Drug Research and Development Enters into Agreement with viDA Therapeutics 13
The Centre For Drug Research Enters Into Co-Development Agreement With F. Hoffmann-La Roche 14
CDRD Enters Into Preferred Collaboration With National Research Council 15
CDRD Enters Into An Agreement With Lead Discovery Center 16
CDRD Enters Into Co-Development Agreement With PANAMP 17
CDRD Enters Into Co-Development Agreement With NGDI-UBC 18
The Centre for Drug Research and Development Enters Into Preferred Collaboration Agreement With Vancouver Prostate Centre 19
CDRD Enters Into An Agreement With Eskitis Institute 20
Licensing Agreements 21
Zucara Therapeutics Enters into Licensing Agreement with Centre for Drug Research and Development 21
The University of British Columbia And CDRD Enter Into Licensing Agreement With Covidien 22
The Centre for Drug Research and Development – Key Competitors 23
Key Employees 24
Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Key Facts 1
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Centre for Drug Research and Development, Deals By Therapy Area, 2010 to YTD 2016 8
The Centre for Drug Research and Development, Medical Devices Deals, 2010 to YTD 2016 9
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Centre for Drug Research and Development Partners with AstraZeneca 12
Centre for Drug Research and Development Enters into Agreement with viDA Therapeutics 13
The Centre For Drug Research Enters Into Co-Development Agreement With F. Hoffmann-La Roche 14
CDRD Enters Into Preferred Collaboration With National Research Council 15
CDRD Enters Into An Agreement With Lead Discovery Center 16
CDRD Enters Into Co-Development Agreement With PANAMP 17
CDRD Enters Into Co-Development Agreement With NGDI-UBC 18
The Centre for Drug Research and Development Enters Into Preferred Collaboration Agreement With Vancouver Prostate Centre 19
CDRD Enters Into An Agreement With Eskitis Institute 20
Zucara Therapeutics Enters into Licensing Agreement with Centre for Drug Research and Development 21
The University of British Columbia And CDRD Enter Into Licensing Agreement With Covidien 22
The Centre for Drug Research and Development, Key Competitors 23
The Centre for Drug Research and Development, Key Employees 24

List of Figures
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The Centre for Drug Research and Development, Medical Devices Deals, 2010 to YTD 2016 9

★調査レポート[The Centre for Drug Research and Development:企業のM&A・提携動向(医療分野)] (コード:GDPH250701D)販売に関する免責事項を必ずご確認ください。
★調査レポート[The Centre for Drug Research and Development:企業のM&A・提携動向(医療分野)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆